Coeptis，S-4归档和Z Squared：有什么交易？

Coeptis提交与Z平方合并有关的S-4。这篇博客文章打破了对投资者的意义。

Coeptis, S-4 Filing, and Z Squared: What's the Deal?

Coeptis，S-4归档和Z Squared：有什么交易？

Coeptis Therapeutics is merging with Z Squared! The company filed an S-4 registration statement with the SEC. Here's a quick look at what this means.

Coeptis Therapeutics与Z平方合并！该公司向SEC提交了S-4注册声明。这是一个快速查看这意味着什么。

The Latest: Coeptis Files S-4 for Z Squared Merger (June 2025)

最新：Z平方合并的Coeptis文件S-4（2025年6月）

Coeptis Therapeutics Holdings, Inc. (COEP) has officially filed a registration statement on Form S-4 with the Securities and Exchange Commission (SEC) regarding its proposed merger with Z Squared Inc. This S-4 includes a preliminary proxy statement/prospectus, meaning things are moving forward, but it's not a done deal yet. The SEC still needs to give it the thumbs up.

Coeptis Therapeutics Holdings，Inc。（COEP）已就其与Z Squared Inc.拟议的合并有关S-4的S-4表格S-4的注册声明。此S-4此S-4包括初步代理声明/招股说明书，这意味着事情正在发展，但还没有完成交易。 SEC仍然需要给它竖起大拇指。

Who Are These Companies Anyway?

这些公司是谁？

Let's break down who's who in this merger:

让我们分解此合并中的谁：

• Coeptis Therapeutics: A biopharmaceutical company focused on cell therapy platforms for cancer, autoimmune, and infectious diseases. They've also got a tech division dabbling in AI-powered marketing and robotic process automation.
• Z Squared Inc: They're all about digital asset compute mining, specifically focusing on Dogecoin (DOGE) and other altcoins.

Why Should You Care?

你为什么要关心？

This merger could mean a significant shift for both companies. Coeptis gets a new revenue stream in the digital asset space, while Z Squared gains access to Coeptis' resources and expertise in the biotech world. For investors, it's a blend of healthcare innovation and crypto mining – a potentially interesting combo.

这次合并可能意味着两家公司的重大转变。 Coeptis在数字资产领域获得了新的收入来源，而Z Squared可以在生物技术世界中获得Coeptis的资源和专业知识。对于投资者而言，这是医疗创新和加密矿业开采的融合，这是一个可能有趣的组合。

What's Next?

接下来是什么？

Coeptis urges investors to read the preliminary proxy statement/information statement/prospectus as well as other documents filed with the SEC because these documents contain important information about Coeptis, Z Squared and the proposed transaction. The preliminary and definitive proxy statement/information statement/prospectus to be included in the registration statement, once available, can be obtained, without charge, at the SEC’s website (www.sec.gov).

Coeptis敦促投资者阅读初步替代声明/信息声明/招股说明书以及向SEC提交的其他文件，因为这些文件包含有关Coeptis，Z Squared和拟议交易的重要信息。在SEC的网站（www.sec.gov）上，可以在不收取的注册声明中包含的初步和确定的代理声明/信息声明/招股说明/招股说明书。

The Fine Print (aka Forward-Looking Statements)

精美的打印（又称前瞻性语句）

As with any announcement like this, there are forward-looking statements involved. These are basically educated guesses about the future, and they come with risks and uncertainties. Don't take everything you read as gospel. Do your own research, folks!

与此类公告一样，涉及前瞻性陈述。这些基本上是对未来的猜测，并且会带来风险和不确定性。不要以您阅读的所有内容为福音。做自己的研究，伙计们！

Final Thoughts: A Biopharma Company Mining Dogecoin?

最终想法：一家生物制药公司挖掘狗狗币？

Honestly, who saw that coming? It's a wild combination, but in today's market, you've gotta stay on your toes. Whether this merger is a stroke of genius or a recipe for disaster remains to be seen. One thing's for sure: it's going to be an interesting ride!

老实说，谁看到了那个？这是一种疯狂的组合，但是在当今的市场中，您必须留在脚趾上。这次合并是天才的中风还是灾难的秘诀，还有待观察。可以肯定的是：这将是一个有趣的旅程！